The Oncosearch | Oncotarget

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Stefania Acciardo, Lionel Mignion, Nicolas Joudiou, Caroline Bouzin, Jean-FranÃ§ois Baurain, Bernard Gallez, BÃ©nÃ©dicte F. Jordan

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16832-16846

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia Research Paper

Wojciech Czardybon, Renata Windak, Aniela GoÅ‚as, MichaÅ‚ GaÅ‚Ä™zowski, Aleksandra Sabiniarz, Izabela Dolata, Magdalena SalwiÅ„ska, PaweÅ‚ Guzik, Magdalena Zawadzka, Ewelina Gabor-Worwa, BoÅ¼ena Winnik, MaÅ‚gorzata Å»urawska, Ewa KolasiÅ„ska, Ewelina Wincza, Marta Bugaj, Monika Danielewicz, Eliza Majewska, Milena Mazan, Grzegorz Dubin, Monika Noyszewska-Kania, Ewa JabÅ‚oÅ„ska, Maciej SzydÅ‚owski, Tomasz Sewastianik, Bartosz PuÅ‚a, Anna Szumera-CieÄ‡kiewicz, Monika Prochorec-Sobieszek, ElÅ¼bieta MÄ…dro, Ewa Lech-MaraÅ„da, Krzysztof Warzocha, Jerome Tamburini, PrzemysÅ‚aw JuszczyÅ„ski, Krzysztof BrzÃ³zka

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16917-16931

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Felix Bremmer, Hubertus Jarry, Valerie Unterkircher, Silke Kaulfuss, Peter Burfeind, Heinz-Joachim Radzun, Philipp StrÃ¶bel, Paul Thelen

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16951-16961

Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer Research Paper

Sergey A. Dyshlovoy, Katharina Otte, Kseniya M. Tabakmakher, Jessica Hauschild, Tatyana N. Makarieva, Larisa K. Shubina, Sergey N. Fedorov, Carsten Bokemeyer, Valentin A. Stonik, Gunhild von Amsberg

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16962-16973

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Cathy B. Moelans, Caroline M.G. van Maldegem, Elsken van der Wall, Paul J. van Diest

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17078-17092

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Rufael Chekol, Viswas Raja Solomon, Elahe Alizadeh, Wendy Bernhard, Darrell Fisher, Wayne Hill, Kris Barreto, John Francis DeCoteau, Angel Casaco Parada, Clarence Ronald Geyer, Humphrey Fonge

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17117-17132

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Tsung-Chieh Lin, Kuan-Wei Huang, Chia-Wei Liu, Yu-Chan Chang, Wei-Ming Lin, Tse-Yen Yang, Michael Hsiao

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17210-17219

Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies Meta-Analysis

Ya Xiao, Ruixue Chen, Minghao Chen, Anling Luo, Dayi Chen, Qiuer Liang, Yunfei Cai, Liguo Chen, Xiaoshan Zhao

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17133-17140

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Yoko Ogino, Akira Sato, Fumiaki Uchiumi, Sei-Ichi Tanuma

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16451-16461

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Miao Wang, Alex Yuang-chi Chang

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16533-16546

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Kazuaki Machioka, Kouji Izumi, Yoshifumi Kadono, Hiroaki Iwamoto, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Ariunbold Natsagdorj, Evan T. Keller, Jian Zhang, Atsushi Mizokami

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 16185-16196

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events Case Report

Tatsuo Kanda, Shin Yasui, Masato Nakamura, Shingo Nakamoto, Koji Takahashi, Shuang Wu, Reina Sasaki, Yuki Haga, Sadahisa Ogasawara, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Yoshihiko Ooka, Eiichiro Suzuki, Tetsuhiro Chiba, Hitoshi Maruyama, Mitsuhiko Moriyama, Naoya Kato

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 16263-16270

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

Nina Hedemann, Christoph Rogmans, Susanne Sebens, Daniela Wesch, Manuel Reichert, Dirk Schmidt-Arras, Hans-Heinrich Oberg, Ulrich Pecks, Marion van Mackelenbergh, JÃ¶rg Weimer, Norbert Arnold, Nicolai Maass, Dirk O. Bauerschlag

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 16043-16058

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

Jong-Kook Lee, Tudor Luchian, Yoonkyung Park

Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15616-15634

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer Research Paper

Mangala Iyengar, Patrick Oâ€™Hayer, Alex Cole, Tara Sebastian, Kun Yang, Lan Coffman, Ronald J. Buckanovich

Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15658-15672

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

Carina Heydt, Sebastian Michels, Kenneth S. Thress, Sven Bergner, JÃ¼rgen Wolf, Reinhard Buettner

Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15418-15434

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma Research Paper

Asuka Morikawa, Tomoatsu Hayashi, Naomi Shimizu, Mana Kobayashi, Kenzui Taniue, Akiko Takahashi, Kota Tachibana, Misato Saito, Ayako Kawabata, Yasushi Iida, Kazu Ueda, Motoaki Saito, Nozomu Yanaihara, Hiroshi Tanabe, Kyosuke Yamada, Hirokuni Takano, Osamu Nureki, Aikou Okamoto, Tetsu Akiyama

Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15266-15274

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia Research Paper

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies Meta-Analysis

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events Case Report

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer Research Paper

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma Research Paper

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft Research Paper

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB Research Paper

miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia Research Paper

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies Meta-Analysis

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events Case Report

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer Research Paper

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma Research Paper

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft Research Paper

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB Research Paper

miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression Research Paper

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper